Naya Biosciences Inc.
13F holders, Q2 2024 (June 30)12holders +1
5new positions
4sold out
$0.85avg. 13F price*
At the end of Q2 2024, 12 institutions reported holding Naya Biosciences Inc. in their 13F filings, up 1 from Q1 2024. 5 opened new positions and 4 sold out. The largest holders were Vanguard Group Inc. ($45K), Geode Capital Management, LLC ($28K) and Two Sigma Securities, LLC ($13K).
- Company
- Naya Biosciences Inc.
- Filed as
- INVO BIOSCIENCE INC (Q2 2024)
- CUSIP
- 44984F401
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $25K |
| Exits | 4 | $30K |
All 13F filers, Q1 2024 → Q2 2024: 36,342 shares bought and 29,084 shares sold, net +7,258 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Vanguard Group Inc. | 0.00% | No change | 54,058 | $45K |
| Geode Capital Management, LLC | 0.00% | Add +31.2% | 32,614 | $28K |
| Two Sigma Securities, LLC | 0.00% | New | 15,968 | $13K |
| Virtu Financial LLC | 0.00% | New | 12,409 | $11K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -26.2% | 5,106 | $4K |
| Osaic Holdings, Inc. | 0.00% | Reduce -55.3% | 250 | $210 |
| Qube Research & Technologies Ltd | 0.00% | New | 100 | $86 |
| FMR LLC | 0.00% | New | 75 | $65 |
| Morgan Stanley | 0.00% | No change | 37 | $31 |
| Bank of America Corp. | 0.00% | New | 28 | $24 |
| Gleason Group, Inc. | 0.00% | No change | 3 | $3 |
| Royal Bank of Canada | 0.00% | Reduce -18.6% | 438 | $0 |
"% of holder's portfolio" is NAYA BIOSCIENCES INC's weight in each manager's 13F, not the share of Naya Biosciences Inc. the manager owns.